Karuna Therapeutics to Announce Second Quarter 2023 Financial Results and Provide General Business Update on Thursday, August 3, 2023
20 Juillet 2023 - 12:30PM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage
biopharmaceutical company driven to create and deliver
transformative medicines for people living with psychiatric and
neurological conditions, today announced that it will host a live
conference call and webcast on Thursday, August 3, 2023 at 8:00
a.m. ET to review second quarter 2023 financial results and provide
a general business update.
A live webcast of the presentation will be available on the
Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 30 days on Karuna’s website following the
completion of the event.
About Karuna Therapeutics Karuna Therapeutics is a
clinical-stage biopharmaceutical company driven to create and
deliver transformative medicines for people living with psychiatric
and neurological conditions. At Karuna, we understand there is a
need for differentiated and more effective treatments that can help
patients navigate the challenges presented by these severe and
disabling disorders. Utilizing our extensive knowledge of
neuroscience, we are harnessing the untapped potential of the brain
in pursuit of novel pathways to develop medicines that make
meaningful differences in peoples’ lives. For more information,
please visit www.karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230720981065/en/
Investors: Alexis Smith +1 (518) 338-8990
asmith@karunatx.com
Media: Bob Josefsberg +1 (646) 734-3584
bjosefsberg@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Karuna Therapeutics (NASDAQ:KRTX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
